The pharmaceutical industry’s approach to data integrity has been historically manual, leveraging physical documentation and potentially unreliable paper-based ...

Forbes contributors publish independent expert analyses and insights. Faculty member at Columbia University. Founder and CEO of OORT. As the world remains fixated on the intensifying war over AI ...

Susan Schniepp, Regulatory Compliance Associates Inc., explains how AI and digital twins speed up pharma batch release and detect data integrity issues with human oversight. In part 2 of a 2-part ...

Artificial intelligence is no longer an emerging technology—it is an embedded reality shaping the way we live, govern and do business. From predictive healthcare to autonomous defense systems, AI is ...